Tag:
Fanapt
Latest Headlines
Latest Headlines
Two drugs, two price-setting tales
As governments worldwide slash prices on prescription meds, drugmakers in the U.S. are raising them. Cancer specialist Celgene ( $CELG ) has raised the price of its Revlimid pill for multiple myeloma
Vanda reaps $200M upfront in Novartis drug pact
Shares of Vanda Pharmaceuticals swiftly shot up this morning after the developer announced a new licensing deal with Novartis that will be worth up to $465 million--with a whopping $200 million of
It's Novartis' prerogative to change its mind
Today's big Novartis news: The Swiss drugmaker has scooped up U.S. and Canadian rights to Vanda Pharmaceuticals' new schizophrenia remedy Fanapt for up to $465 million in up-front and milestone
Vanda gets $200M upfront in Novartis drug pact
Shares of Vanda Pharmaceuticals swiftly shot up this morning after the developer announced a new licensing deal with Novartis that will be worth up to $265 million--with a whopping $200 million of
